These patches are designed to deliver GLP-1 analogues through the skin and into the bloodstream, offering a potential alternative to weekly or daily injections currently used for type 2 diabetes and weight management
On top of this, risks may include: No FDA-Approval for Safety or Effectiveness Unlike prescription GLP-1 drugs, which undergo rigorous testing, these patches are sold as supplements and are not reviewed by the FDA for effectiveness before being marketed, and quality may vary by the product
Body aches may temporarily reappear with each dose increase, but they typically resolve within 1-2 weeks
No guesswork involved
In this post, we will explore what GLP-1 medications are, how they interact with the plasma donation process, and the broader implications of donating plasma while on such treatments
Sivertsen, J., Rosenmeier, J., Holst, J